About

The Institute of Preventive Medicine (IPM) is a research institute at Bispebjerg and Frederiksberg Hospital, a University hospital in the Capital Region of Denmark. Its research is aimed at improving the knowledge for the prevention of disease and promotion of health across a wide range of health problems, such as cancer, cardiovascular disease, obesity and general mortality. The main line of research is based on analytical epidemiology, which includes both environmental and genetic factors as equally important etiological contributors. The Institute is engaged in a number of international collaborative research activities and academic education.

Expertise

The Institute coordinates research dealing with population-based studies, covering the whole age span from pregnancy to old age. Institute of Preventive Medicine’s areas of expertise include large observational cohort studies, lifecourse epidemiology methods, biostatistics and register linkages with particular focus on research in obesity and obesity-related topics.

Our team

Dr Jennifer L. Baker

Associate Professor and DynaHEALTH Principle Investigator

Jennifer is an associate professor at the University of Copenhagen, leader of a research group on lifecourse epidemiology and lead investigator of several national and international research projects. Jennifer’s research interests focus on understanding how early life body size, growth and exposures affect health across the lifespan.

Dr Lise Geisler Bjerregaard

Postdoctoral researcher

Lise is a postdoctoral researcher with expertise in epidemiology and public health with a focus on longitudinal studies of body weight, infant feeding and infant growth studied in population-based studies.

Dr Lars Ängquist

Lars, a statistician, has expertise in applied research within general epidemiology, biostatistics and genetic epidemiology.

Dr Esther Zimmermann

Esther, a postdoctoral researcher, has expertise in epidemiology and her current research focuses on childhood body size and growth in relation to adult type 2 diabetes and other related outcomes.

Professor Thorkild I.A. Sørensen

Professor of Metabolic and Clinical Epidemiology at the University of Copenhagen and Director of the Institute of Preventive Medicine.

Thorkild has long-standing research interests in obesity, its causes, development, occurrence, distribution changes over time and place, psychological, medical and societal implications and complications, and in opportunities for prevention and cure, addressed by methods in genetic, metabolic, clinical and general epidemiology. His current primary interest is in the development of a theory that unifies the evidence about why obesity develops and why it is harmful.

Role in this project

The Institute of Preventive Medicine is involved in research tasks in Work Packages 1, 3 and 4 and is responsible for large-scale life-course studies on cohort data under Work Package 3.